Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Filtration on Autologous Serum Eye Drops
Sponsor: University Hospital, Limoges
Summary
Dry eye disease accounts for nearly 25% of ophthalmology consultations, making it a commonly encountered condition. When conventional treatments fail autologous serum in the form of eye drops, have been proposed as a therapeutic option. With the aim of standardizing the preparation of autologous serum eye drops in France, the main objective is to describe the absolute and relative differences (before and after filtration) in the concentrations of active molecules in the autologous serum of patients suffering from severe dry eye disease.
Official title: Optimization of Autologous Serum Eye Drops: Study of Filtration on Active Molecule Concentration in Patients With Dry Eye Disease (IFilCoSA)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-04-30
Completion Date
2027-04-29
Last Updated
2026-02-12
Healthy Volunteers
No
Conditions
Interventions
Serum dosage of TGF-β, IGF-1, EGF, Fibronectin and Vitamin A
Dosage of active molecules of autologous serum: TGF β, IGF 1, EGF, fibronectin and vitamin A
Locations (1)
CHU Limoges
Limoges, France